Probmet

Copenhagen, Denmark

Probmet is a precision oncology therapeutics company developing treatments for cancer.

$548K raised

Mar 2022

Convertible Note

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Probmet raised?

Probmet has raised $548K in total funding. The most recent round was Convertible Note. The last funding was announced in March 2022.

Who are Probmet's investors?

Probmet's investors include BioInnovation Institute.

Where is Probmet headquartered?

Probmet is headquartered in Copenhagen, Denmark.

What does Probmet do?

Probmet is a precision oncology therapeutics company developing treatments for cancer.

What stage is Probmet at?

Probmet is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 15, 2022.

MLA

"Probmet — Funding & Investors." VCBacked, March 15, 2022, https://www.vcbacked.co/company/probmet. Accessed July 2, 2026.

APA

VCBacked. (2022). Probmet — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/probmet

Wikipedia (cite web)

{{cite web |title=Probmet — Funding & Investors |url=https://www.vcbacked.co/company/probmet |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 15, 2022.